✨ Free AI Report
Lonza Group AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Lonza Group AG
Research Preview

Lonza Group AG: Business Overview, Financials & Competitive Analysis

Lonza is a contract development and manufacturing organization operating across four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. The company provides development and manuf...

Analyst-debate audio for Lonza Group AG

AskCyborg analysts argue the bull and bear cases for Lonza Group AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Lonza Group AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
8/ 10Strong

Cyborg Score thesis

Diversified CDMO leader with strong profitability expansion, well-positioned for sustained double-digit growth in...

Read the full analyst-debate transcript →
Industry Contract Development and Manufacturing Organization (CDMO) / Pharmaceutical Manufacturing Services
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Lonza Group AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Lonza Group AG Overview

Pro stress-test →

Lonza is a contract development and manufacturing organization operating across four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply.

Strategic Profile

Pro stress-test →

Lonza's business model has proven resilient, effectively diversifying risks across the broadest technology offering, commercial portfolio and global manufacturing footprint in the CDMO industry. The strong economic rationale to outsource to CDMOs remains unchanged for large pharma and biotech companies to enable economically efficient global pharmaceutical supply.

Competitive Landscape

Pro stress-test →

Key competitors include Siegfried Holding, KBI BioPharma, Patheon, CordenPharma, and Vetter Pharma. Lonza maintains competitive advantage through its diversified technology platform, extensive manufacturing footprint, and strong customer relationships with large pharmaceutical and biotech companies.

Industry Context

Lonza Group AG operates in Contract Development and Manufacturing Organization (CDMO) / Pharmaceutical Manufacturing Services.

Key facts

Founded: 1897 · Headquarters: Basel, Switzerland · Revenue: $8.17B · Market cap: $49.6B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Lonza Group AG.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Lonza Group AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Siegfried HoldingSwiss CDMO competitor→PatheonIntegrated CDMO services→CordenPharmaContract manufacturer of small molecules→Vetter PharmaFill-finish and CDMO provider→

Compare Lonza Group AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Lonza Group AG operates in Contract Development and Manufacturing Organization (CDMO) / Pharmaceutical Manufacturing Services. See how the rest of the sector scores on the Cyborg framework.

Browse Contract Development and Manufacturing Organization (CDMO) / Pharmaceutical Manufacturing Services research →
NEW · MCP server

Ask your AI assistant about Lonza Group AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Lonza Group AG and its top competitor on Cyborg Score”
“What did Lonza Group AG do this quarter?”
“Is Lonza Group AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Lonza Group AG do?+
Lonza is a contract development and manufacturing organization operating across four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. The company provides development and manuf...
What is Lonza Group AG's Cyborg Score?+
Lonza Group AG has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Lonza Group AG's main competitors?+
Named competitors include Siegfried Holding, Patheon, CordenPharma, Vetter Pharma. The full competitive landscape is in the AskCyborg report.
How can I get the full Lonza Group AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Lonza Group AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Lonza Group AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Dave Inc.9nVent Electric plc9Elbit Systems Ltd.9Vertiv Holdings Co9Barrick Mining Corporation9GE Vernova Inc.9Applied Materials, Inc.9Eli Lilly and Company9Microsoft Corporation8Dätwyler Holding AG8Cingulate Inc.8Tristel plc8cBrain8Electrovaya Inc.8Kits Eyecare Ltd.8Sukoon Insurance8Lumax Industries Limited8Tanla Platforms Limited